|
For Patients
Collection and transport of the tumor cells and other associated blood or tissue collections are the first steps. Optimal media, conditions, tubes and procedures for collection, transport, and chain of custody will be provided in the tumor collection kit products made by INCELL. Patients, Physicians and INCELL work together to coordinate collection and transport of samples. |
 |
|
 |
Tumor tissues are processed into cells. Some are frozen away in suspended animation for future use and some are cultured for laboratory testing. INCELL staff and collaborators have decades of experience and the company has proprietary technologies for processing, culture, cell expansion, and cryopreservation. |
Testing and characterizing the cells follows expansion of the cultures in the laboratory to larger cell numbers. Cell-based assays will be designed to provide a rational approach to personalized medicine for cancer.
Test options will include characterization of the cells for growth, genomic and proteomic biomarkers, and susceptibility to specific therapies that kill or inhibit the tumor cells, combined with other factors.
These are expected to suggest a “personalized medicine” approach based on the unique features of the tumor cells compared to normal cells and tumors of the same type. This should lead to pharmaceutical, immunotherapy, vaccines, gene therapy, or other therapies specifically targeted to the unique features of the tumor cells for a rational therapeutic approach using already approved anti-cancer treatments and newly emerging therapies. |
|
|
